ChakravartyAChuang-SteinCJiangQ. Evaluation and review of strategies to assess cardiovascular risk in clinical trials in patients with type 2 diabetes mellitus. Submitted for publication, 2014.
2.
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for industry and investigators. Safety reporting requirements for INDs and BA/BE studies, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm227351.pdf (2012, acces-sed 27 October 2014).
